45
Sumitomo Pharma
4506.T·TSEOsaka JPFounded 20058,000 employees
Mid CappharmaPublicCNSOncologyRare Disease
Platform: iPSC Regen
Market Cap
$4B
All Drugs
3
Clinical Trials
6
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (4506.T)
Loading 4506.T stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 450-3790 | 450-3790 | Preclinical | 2 | LAG-3 | T2D | ||
| Zenocagene | 450-1089 | Approved | 2 | IL-23 | Prostate CaHuntington's | ||
| Mavulucimab | 450-2683 | NDA/BLA | 2 | CDK4/6 | CSU |
SEC Filings & Financial Documents
SEC filings are not available for TSE-listed companies.
Sumitomo Pharma trades on TSE (JP). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (5)